Testimony on Liprotamase

Testimony to the FDA Gastrointestinal Drug Advisory Committee
RegardingLiprotamase – Risk : Benefit Assessment Ethics of Further Clinical Trials

Michael Carome, M.D.
Sidney Wolfe, M.D.

View testimony as PDF